Atlas Trials

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

Clinical trial NCT02308085 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02308085
Sponsor
ETOP IBCSG Partners Foundation
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Early Breast Cancer
Start date
2014-12-04
Primary completion
2025-05-15
Enrollment
518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.